The exogenous opioid peptides and DPPIV serum activity in infants with apnoea expressed as apparent life threatening events (ALTE)

Neuropeptides

Volumn 45, Issue 3, 2011, Pages 189-195

  Wasilewska, Jolanta ^b   Sienkiewicz Szłapka, Edyta ^a   Kuźbida, Ewa ^a   Jarmołowska, Beata ^a   Kaczmarski, Maciej ^b   Kostyra, Elzbieta ^a  

^a UNIVERSITY OF WARMIA AND MAZURY IN OLSZTYN   (Poland)

^b MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

Author keywords

Casomorphin; ALTE; Breast feeding; Dipeptidyl peptidase iv; Formula feeding; Opioid peptides; SIDS

Indexed keywords

BETA CASOMORPHIN 7; DIPEPTIDYL PEPTIDASE IV; OPIATE PEPTIDE; UNCLASSIFIED DRUG;

APNEA; APPARENT LIFE THREATENING EVENT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; HUMAN; INFANT; PRIORITY JOURNAL; PROTEIN CONTENT; RESPIRATION DEPRESSION; SUDDEN INFANT DEATH SYNDROME;

ANIMALS; APNEA; CATTLE; DIPEPTIDYL PEPTIDASE 4; ENDORPHINS; HUMANS; INFANT; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; SUDDEN INFANT DEATH;

BOVINAE;

EID: 79955606531     PISSN: 01434179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.npep.2011.01.005     Document Type: Article

References (60)

1. Beckwith J.B. Defining the sudden infant death syndrome. Arch. Pediatr. Adolesc. Med. 2003, 157(3):286-290.
2. Blackwell C., Moscovis S., Gordon A., Al Madani O., Hall S., Gleeson M., Scott R., Roberts-Thompson J., Weir D.M., Busuttil A. Cytokine responses and sudden infant death syndrome: genetic, developmental, and environmental risk factors. J. Leukoc. Biol. 2005, 78:1242-1254.
3. Blair P.S., Sidebotham P., Evason-Coombe C., Edmonds M., Heckstall-Smith E.M., Fleming P. Hazardous cosleeping environments and risk factors amenable to change: case-control study of SIDS in south west England. BMJ 2009, 339:11. doi: 10.1136/bmj.b3666.
4. Boonacker E., Van Noorden C.J.F. The multifunctional or moonlighting protein CD26/DPPIV. Eur. J. Cell Biol. 2003, 82:35-73.
5. Caporale C., Fontanella A., Petrilli P., Pucci P., Molinaro M.F., Picone D., Auricchio S. Isolation and characterization of dipeptidyl peptidase IV from human meconium. Functional role of beta-casomorphins. FEBS Lett. 1985, 184:273-277.
6. Carpenter R.G., Irgens L.M., Blair P.S., England P.D., Fleming P., Huber J., Jorch G., Schreuder P. Sudden unexplained infant death in 20 regions in Europe: case control study. Lancet 2004, 363:185-191.
7. Chabance B., Marteau P., Rambaud J., Migliore-Samour D., Boynard M., Perrotin P., Guillet R., Jollès P., Fiat A. Casein peptide release and passage to the blood in humans during digestion of milk or yogurt. Biochimie 1998, 80(2):155-165.
8. Cohen M., Fruitier-Arnaudin I., Piot J.M. Hemorfins: substrates and/or inhibitors of dipeptidyl peptidase IV - Hemorfins N-terminus sequence influence on the interaction between hemorfins and DPPIV. Biochimie 2004, 86:31-37.
9. De Noni I., Cattaneo S. Occurrence of β-casomorphins 5 and 7 in commercial dairy products and their digests following in vitro simulated gastro-intestinal digestion. Food Chem. 2010, 119:560-566.
10. Dubynin V.A., Ivleva Y.A., Beliaeva I.A., Dobriakova I.V., Andreeva L.A., Kamenski A.A. Influence of acute and chronic administrations of beta-casomorphins on the maternal motivation in albino rats. Ross Fiziol Zh Im I M Sechenova 2005, 91(1):80-88.
11. Dubynin V.A., Ivleva Y.A., Stovolosov I.S., Belyaeva Y.A., Dobryakova Y.V., Andreeva L.A., Alfeeva L.Y., Kamenskii A.A., Myasoedov N.F. Effects of beta-casomorphines on mother-oriented (" child's" ) behavior of white rats. Dokl. Biol. Sci. 2007, 412:1-4.
12. Duncan J.R., Paterson D.S., Hoffman J.M., Mokler D.J., Borenstein N.S., Belliveau R.A., Krous H.F., Haas E.A., Stanley C., Nattie E.E., Trachtenberg F.L., Kinney H.C. Brainstem serotonergic deficiency in Sudden Infant Death Syndrome. JAMA 2010, 303(5):430-437.
13. Dunne K., Matthews T. Near-miss sudden infant death syndrome: clinical findings and management. Pediatrics 1987, 79:889-893.
14. Durinx Ch., Lambeir A.M., Bosmans E., Flamagne J.B., Berghmans R., Haemers A., Scharpe S., De Meester I. Molecular characterization of dipeptidyl peptidase activity in serum. Soluble CD26/dipeptidyl peptidase IV is responsible for the release of X-Pro dipeptides. Eur. J. Biochem. 2000, 267:5608-5613.
15. Elitsur Y., Luk G. Beta-casomorphin (BCM) and human colonic lamina propria lymphocyte proliferation. Clin. Exp. Immunol. 1991, 85(3):493-497.
16. Froetschel M. Bioactive peptides in digesta that regulate gastrointestinal function and intake. J. Anim. Sci. 1996, 74(10):2500-2508.
17. Ganapathy V., Miyauchi S. Transport systems for opioid peptides in mammalian tissues. Am. Assoc. Pharm. Sci. J. 2005, 7(4):852-856.
18. Harada M., Fukasawa K.M., Fukasawa K., Nagatsu T. Inhibitory action of proline-containing peptides on Xaa-Pro-dipeptidylaminopeptidase. Biochim. Biophys. Acta 1982, 705:288-290.
19. Hedner J., Hedner T. B-Casomorphins induce apnea and irregular breathing in adult rats and newborn rabbits. Life Sci. 1987, 41(20):2303-2312.
20. Hernandez-Ledesma B., Amigo L., Ramos M., Recio I. Release of angiotensin converting enzyme-inhibitory peptides by simulated gastrointestinal digestion of infant formulas. Int. Dairy J. 2004, 14:889-898.
21. Herrera-Marschitz M., Terenius L., Grehn L., Ungerstedt U. Rotational behaviour produced by intranigral injections of bovine and human beta-casomorphins in rats. Psychopharmacology (Berlin) 1989, 99(3):357-361.
22. Hildebrandt M., Reutter W., Arck P., Rose M., Klapp B.F. A guardian angel: the involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition and immune defence. Clin. Sci. 2000, 99:93-104.
23. Jarmolowska B., Bielikowicz K., Iwan M., Sidor K., Kostyra E., Kaczmarski M. Serum activity of dipeptidyl peptidase IV (DPPIV; EC 3.4.14.5) in breast-fed infants with symptoms of allergy. Peptides 2007, 28:678-682.
24. Jarmolowska B., Sidor K., Iwan M., Bielikowicz K., Kaczmarski M., Kostyra E., Kostyra H. Changes of β-casomorphin content in human milk during lactation. Peptides 2007, 28(10):1982-1986.
25. Jarmolowska B., Sienkiewicz-Szlapka E., Kostyra E., Kostyra H., Mierzejewska D., Marciniak-Darmochwał K. Opioid activity of Humana formula for newborns. J. Sci. Food Agric. 2007, 87:2247-2250.
26. Jinsmaa Y., Yoshikawa M. Enzymatic release of neocasomorphin and β-casomorphin from bovine β-casein. Peptides 1999, 20:957-962.
27. Jorch G., Tapiainen T., Bonhoeffer J., Fischer T.K., Heininger U., Hoet B., Kohl K.S., Lewis E.M., Meyer C., Nelson T., Sandbu S., Schlaud M., Schwartz A., Varricchio F., Wise R.P. Unexplained sudden death, including sudden infant death syndrome (SIDS), in the first and second years of life: case definition and guidelines for collection, analysis, and presentation of immunization safety data. Vaccine 2007, 25(31):5707-5716.
28. Kahn A. Recommended clinical evaluation of infants with an apparent life-threatening event. Consensus document of the European Society for the study and prevention of infant death. Eur. J. Pediatr. 2004, 163:108-115.
29. Kamiński S., Cieślińska A., Kostyra E. Polymorphism of bovine beta-casein and its potential effect on human health. J. Appl. Genet. 2007, 48(3):189-198.
30. Kost N.V., Sokolov O.Y., Kurasova O.B., Dmitriev A.D., Tarakanova J.N., Gabaeva M.V., Zolotarev Y.A., Dadayan A.K., Grachev S.A., Korneeva E.V., Mikheeva I.G., Zozulya A.A. B-Casomorphins-7 in infants on different type of feeding and different levels of psychomotor development. Peptides 2009, 30:1854-1860.
31. Kostyra E., Sienkiewicz-Szlapka E., Jarmolowska B., Krawczuk S., Kostyra H. Opioid peptides derived from milk proteins. Pol. J. Nutr. Sci. 2004, 13:25-35.
32. Kreil G., Umbach M., Brantl V., Teschemacher H. Studies of the enzymatic degradation of β-casomorphins. Life Sci. 1983, 33(1):137-140.
33. Kurek M., Czerwionka-Szaflarska M., Doroszewska G. Pseudoallergic skin reactions to opiate sequences of bovine casein in healthy children. Rocz. Akad. Med. Bialymst. 1995, 40:480-485.
34. Lindström L.H., Nyberg F., Terenius L., Bauer K., Besev G., Gunne L.M., Lyrenäs S., Willdeck-Lund G., Lindberg B. CSF and plasma beta-casomorphin-like opioid peptides in post-partum psychosis. Am. J. Psychiatry 1984, 141(9):1059-1066.
35. Lucas A., Bloom S.R., Green A.A. Gastrointestinal peptides and the adaptation to extrauterine nutrition. Can. J. Physiol. Pharmacol. 1985, 63:527-537.
36. Maes M., Goossens F., Lin A., De Meester I., Van Gastel A., Scharpe S. Effects of psychological stress on serum prolyl endopeptidase and dipeptidyl peptidase IV activity in humans: higher serum prolyl endopeptidase activity is related to stress-induced anxiety. Psychoneuroendocrinology 1998, 23(5):485-495.
37. Mage, D.T., Donner, M., 2009. A unifying theory for SIDS. International Journal of Pediatrics: 10. doi: doi:10.1155/2009/368270.
38. Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory peptides. Reg. Pept. 1999, 85:2-24.
39. Myer E.C., Morris D.L., Adams M.L., Brase D.A., Dewey W.L. Increased cerebrospinal fluid beta-endorphin immunoreactivity in infants with apnea and siblings of victims of sudden infant death syndrome. J. Pediatr. 1987, 111(5):660-666.
40. Pasi A., Mahler H., Lansel N., Bernasconi C., Messiha F.S. B-Casomorphin-immunoreactivity in the brain stem of human infant. Res. Commun. Chem. Pathol. Pharmacol. 1993, 80(3):305-322.
41. Read L.C., Lord A.P., Brantl V., Koch G. Absorption of beta-casomorphins from autoperfused lamb and piglet small intestine. Am. J. Physiol. - Gastrointest. Liver Physiol. 1990, 259:443-452.
42. Scanff P., Yvon M., Thirouin S., Pelissier J.P. Characterization and kinetics of gastric emptying of peptides derived from milk proteins in the preruminant calf. J. Dairy Res. 1992, 59(4):437-447.
43. Shimizu M., Tsunogai M., Arai S. Transepithelial transport of oligopeptides in the human intestinal cell, Caco-2. Peptides 1997, 18(5):681-687.
44. Sienkiewicz-Szlapka E., Jarmolowska B., Krawczuk S., Kostyra E., Kostyra H., Iwan M. Contents of agonistic and antagonistic opioid peptides in different cheese varieties. Int. Dairy J. 2009, 19(4):258-263.
45. Sienkiewicz-Szlapka E., Jarmolowska B., Krawczuk S., Kostyra E., Kostyra H., Bielikowicz K. Transport of bovine milk-derived opioid peptides across a Caco-2 monolayer. Int. Dairy J. 2009, 19(4):252-257.
46. Singh M., Rosen C.L., Chang K.J., Haddad G. Plasma β-Casomorphin-7 immunoreactive peptide increase after milk intake in newborn but not in adult dogs. Pediatr. Res. 1989, 26(1):34-38.
47. Sokolov O.Y., Pryanikova N.A., Kost N.V., Zolotarev Y.A., Ryukert E.N., Zozulya A.A. Reactions between β-casomorphins-7 and 5-HT2-serotonin receptors. Bull. Exp. Biol. Med. 2005, 140(5):582-584.
48. Storm H., Reichelt C.L., Rognum T.O. Beta-endorphin, human caseomorphin and bovine caseomorphin immunoreactivity in CSF in sudden infant death syndrome and controls. Prog. Clin. Biol. Res. 1990, 328:327-330.
49. Sturner R.A., Chang K.J. Opioid peptide content in infant formulas. Pediatr. Res. 1988, 23:4-10.
50. Sturner R.A., Chang K.J. Opioid peptide content of predigested infant formulas. Pediatr. Res. 1991, 29:A670.
51. Sun Z., Cade J.R., Fregly M.J., Privette R.M. Beta-casomorphin induces Fos-like immunoreactivity in discrete brain regions relevant to schizophrenia and autism. Autism 1999, 3(1):67-83.
52. Sun Z., Zhang Z., Wang X., Cade R., Elmer Z., Fregly M. Relation of beta-casomorphin to apnea in sudden infant death syndrome. Peptides 2003, 24:937-943.
53. Teschemacher H. Opioid receptor ligands derived from food proteins. Curr. Pharm. Des. 2003, 9:1331-1344.
54. Tiruppathi C., Miyamoto Y., Ganapathy V., Roesel R.A., Whitford G.M., Leibach F.H. Hydrolysis and transport of proline-containing peptides in renal brush-border membrane vesicles from dipeptidyl peptidase IV-positive and dipeptidyl peptidase IV-negative rat strains. J. Biol. Chem. 1990, 265(3):1476-1483.
55. Uematsu T., Urade M., Yamaoka M., Yoshioka W. Reduced expression of dipeptidyl peptidase (DPP) IV in peripheral blood T lymphocytes of oral cancer patients. J. Oral Pathol. Med. 1996, 25:507-512.
56. Umbach M., Teschemacher H., Praetorius K., Hirschhäuser R., Bostedt H. Demonstration of a β-casomorphin immunoreactive material in the plasma of newborn calves after milk intake. Regul. Pept. 1985, 12(3):223-230.
57. Vissinga C.S., Dirven C.J., Steinmeyer F.A., Benner R., Boersma W.J. Deterioration of cellular immunity during aging. The relationship between age-dependent impairment of delayed-type hypersensitivity reactivity, interleukin-2 production capacity, and frequency of Thy-1+, Lyt-2- cells in C57BL/Ka and CBA/Rij mice. Cell. Immunol. 1987, 108(2):323-334.
58. Wasilewska J., Semeniuk J., Jarocka-Cytra E., Kaczmarski M., Kowalczuk M., Chrzanowska U. Causes of sleep apnea in infants with ALTE syndrome. Sen. 2007, 7(2):81-87.
59. Weaver L.T. Breast and gut: the relationship between lactating mammary function and neonatal gastrointestinal function. Proc. Nutr. Soc. 1992, 51:155-163.
60. Zagon I.S., McLaughlin P.J. Identification of opioid peptides regulating proliferation of neurons and glia in the developing nervous system. Brain Res. 1991, 542:318-323.